270 related articles for article (PubMed ID: 24173224)
21. RNA interference-mediated virus clearance from cells both acutely and chronically infected with the prototypic arenavirus lymphocytic choriomeningitis virus.
Sánchez AB; Perez M; Cornu T; de la Torre JC
J Virol; 2005 Sep; 79(17):11071-81. PubMed ID: 16103158
[TBL] [Abstract][Full Text] [Related]
22. Arenavirus Quasispecies and Their Biological Implications.
Grande-Pérez A; Martin V; Moreno H; de la Torre JC
Curr Top Microbiol Immunol; 2016; 392():231-76. PubMed ID: 26472215
[TBL] [Abstract][Full Text] [Related]
23. A multivalent vaccination strategy for the prevention of Old World arenavirus infection in humans.
Botten J; Whitton JL; Barrowman P; Sidney J; Whitmire JK; Alexander J; Kotturi MF; Sette A; Buchmeier MJ
J Virol; 2010 Oct; 84(19):9947-56. PubMed ID: 20668086
[TBL] [Abstract][Full Text] [Related]
24. A Map of the Arenavirus Nucleoprotein-Host Protein Interactome Reveals that Junín Virus Selectively Impairs the Antiviral Activity of Double-Stranded RNA-Activated Protein Kinase (PKR).
King BR; Hershkowitz D; Eisenhauer PL; Weir ME; Ziegler CM; Russo J; Bruce EA; Ballif BA; Botten J
J Virol; 2017 Aug; 91(15):. PubMed ID: 28539447
[TBL] [Abstract][Full Text] [Related]
25. Arenavirus reverse genetics: new approaches for the investigation of arenavirus biology and development of antiviral strategies.
Emonet SE; Urata S; de la Torre JC
Virology; 2011 Mar; 411(2):416-25. PubMed ID: 21324503
[TBL] [Abstract][Full Text] [Related]
26. Arenavirus Genome Rearrangement for the Development of Live Attenuated Vaccines.
Cheng BY; Ortiz-Riaño E; de la Torre JC; Martínez-Sobrido L
J Virol; 2015 Jul; 89(14):7373-84. PubMed ID: 25972555
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of Arenaviruses by Combinations of Orally Available Approved Drugs.
Herring S; Oda JM; Wagoner J; Kirchmeier D; O'Connor A; Nelson EA; Huang Q; Liang Y; DeWald LE; Johansen LM; Glass PJ; Olinger GG; Ianevski A; Aittokallio T; Paine MF; Fink SL; White JM; Polyak SJ
Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33468464
[TBL] [Abstract][Full Text] [Related]
28. Development of live-attenuated arenavirus vaccines based on codon deoptimization.
Cheng BY; Ortiz-Riaño E; Nogales A; de la Torre JC; Martínez-Sobrido L
J Virol; 2015 Apr; 89(7):3523-33. PubMed ID: 25589652
[TBL] [Abstract][Full Text] [Related]
29. Novel strategies for development of hemorrhagic fever arenavirus live-attenuated vaccines.
Martinez-Sobrido L; de la Torre JC
Expert Rev Vaccines; 2016 Sep; 15(9):1113-21. PubMed ID: 27118328
[TBL] [Abstract][Full Text] [Related]
30. Arenavirus extinction through lethal mutagenesis.
de la Torre JC
Virus Res; 2005 Feb; 107(2):207-14. PubMed ID: 15649566
[TBL] [Abstract][Full Text] [Related]
31. The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies.
Perez M; Craven RC; de la Torre JC
Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12978-83. PubMed ID: 14563923
[TBL] [Abstract][Full Text] [Related]
32. Molecular characterization of the processing of arenavirus envelope glycoprotein precursors by subtilisin kexin isozyme-1/site-1 protease.
Burri DJ; Pasqual G; Rochat C; Seidah NG; Pasquato A; Kunz S
J Virol; 2012 May; 86(9):4935-46. PubMed ID: 22357276
[TBL] [Abstract][Full Text] [Related]
33. A Highly Conserved Leucine in Mammarenavirus Matrix Z Protein Is Required for Z Interaction with the Virus L Polymerase and Z Stability in Cells Harboring an Active Viral Ribonucleoprotein.
Iwasaki M; de la Torre JC
J Virol; 2018 Jun; 92(11):. PubMed ID: 29593035
[TBL] [Abstract][Full Text] [Related]
34. [Neutralization test for lymphocytic choriomeningitis virus for distinguishing between two arenavirus infections in Argentina].
Ambrosio AM; Riera L; Saavedra MC; Sottosanti JJ
Rev Argent Microbiol; 2001; 33(4):235-40. PubMed ID: 11833256
[TBL] [Abstract][Full Text] [Related]
35. CP100356 Hydrochloride, a P-Glycoprotein Inhibitor, Inhibits Lassa Virus Entry: Implication of a Candidate Pan-Mammarenavirus Entry Inhibitor.
Takenaga T; Zhang Z; Muramoto Y; Fehling SK; Hirabayashi A; Takamatsu Y; Kajikawa J; Miyamoto S; Nakano M; Urata S; Groseth A; Strecker T; Noda T
Viruses; 2021 Sep; 13(9):. PubMed ID: 34578344
[TBL] [Abstract][Full Text] [Related]
36. Interactome analysis of the lymphocytic choriomeningitis virus nucleoprotein in infected cells reveals ATPase Na+/K+ transporting subunit Alpha 1 and prohibitin as host-cell factors involved in the life cycle of mammarenaviruses.
Iwasaki M; Minder P; Caì Y; Kuhn JH; Yates JR; Torbett BE; de la Torre JC
PLoS Pathog; 2018 Feb; 14(2):e1006892. PubMed ID: 29462184
[TBL] [Abstract][Full Text] [Related]
37. Cellular endosomal potassium ion flux regulates arenavirus uncoating during virus entry.
Shaw AB; Tse HN; Byford O; Plahe G; Moon-Walker A; Hover SE; Saphire EO; Whelan SPJ; Mankouri J; Fontana J; Barr JN
mBio; 2024 Jun; ():e0168423. PubMed ID: 38874413
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive Interactome Analysis Reveals that STT3B Is Required for N-Glycosylation of Lassa Virus Glycoprotein.
Zhu S; Wan W; Zhang Y; Shang W; Pan X; Zhang LK; Xiao G
J Virol; 2019 Dec; 93(23):. PubMed ID: 31511384
[TBL] [Abstract][Full Text] [Related]
39. Receptor use by pathogenic arenaviruses.
Reignier T; Oldenburg J; Noble B; Lamb E; Romanowski V; Buchmeier MJ; Cannon PM
Virology; 2006 Sep; 353(1):111-20. PubMed ID: 16797051
[TBL] [Abstract][Full Text] [Related]
40. Targeting the proteolytic processing of the viral glycoprotein precursor is a promising novel antiviral strategy against arenaviruses.
Rojek JM; Pasqual G; Sanchez AB; Nguyen NT; de la Torre JC; Kunz S
J Virol; 2010 Jan; 84(1):573-84. PubMed ID: 19846507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
